Final answer:
Baseline labs monitored for TNF inhibitors include a complete blood count, liver function tests, hepatitis B and C serologies, and tuberculosis screening, among others. These tests help ensure patient safety and tailor treatment to individual needs. Continuous monitoring is necessary throughout treatment to manage potential side effects.
Step-by-step explanation:
The baseline labs that should be monitored for patients receiving TNF inhibitors typically include a variety of tests to screen for potential complications and to ensure the safety and suitability of this class of drugs for the individual. Common labs include a complete blood count (CBC), liver function tests, hepatitis B and C serologies, tuberculosis screening often with a PPD skin test or QuantiFERON-TB Gold test, and sometimes a chest X-ray or other imaging if needed to check for latent tuberculosis. In some cases, depending on the patient's medical history and concurrent medications, additional tests such as renal function tests, urine analysis, and HIV screening may be ordered. Moreover, for patients with relevant comorbid conditions, like heart failure or demyelinating diseases, specific assessments might be necessary. Periodic monitoring continues throughout treatment with TNF inhibitors to detect adverse effects early.